ZBED6-Driven Nucleotide Metabolic Reprogramming Improves Sensitivity to anti-PD1 Therapy in NK/T Cell Lymphoma

Drug Resistance Updates · Published 2026-07-01 · DOI 10.1016/j.drup.2026.101466

Authors (12)

Cailu Song, Wenjian Liu, Xiaofang Xie, Cheng Peng, Lewei Zhu, Lingrui Liu, Yutian Zou, Xiaoming Xie, Hailin Tang, Jia Zhu, Chengcheng Liu, Hua Wang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Song, C., Liu, W., Xie, X., et al. (2026). ZBED6-Driven Nucleotide Metabolic Reprogramming Improves Sensitivity to anti-PD1 Therapy in NK/T Cell Lymphoma. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2026.101466

Related articles